Treatment With Namenda in Women at Risk for Cognitive Decline

NCT00242632 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Dementia

Interventions

DRUG: Namenda

Sponsor

Stanford University

Collaborators

[object Object]